Near-infrared-labeled tetracycline derivative is an effective marker of bone deposition in mice

Analytical Biochemistry

Volumn 416, Issue 2, 2011, Pages 167-173

  Kovar, Joy L ^a   Xu, Xinshe ^a   Draney, Dan ^a   Cupp, Andrea ^b   Simpson, Melanie A ^b   Michael Olive, D ^a  

^a LI COR BIOSCIENCES   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Fluorescence microscopy; Immunofluorescent assay; IRDye 800CW; Mineralization; Molecular imaging; Near infrared; Tetracycline derivative; Whole animal imaging

Indexed keywords

AMINO ACIDS; FLUORESCENCE; FLUORESCENCE MICROSCOPY; INFRARED DEVICES; MAMMALS; MINERALOGY; MOLECULAR IMAGING; PHOSPHATE MINERALS;

IMMUNOFLUORESCENT ASSAYS; IRDYE 800CW; MINERALIZATION; NEAR INFRARED; WHOLE ANIMAL IMAGING;

BONE;

CALCEIN; DIGLYCINE; TETRACYCLINE DERIVATIVE; BIOLOGICAL MARKER; FLUORESCEIN DERIVATIVE; INDOLE DERIVATIVE; IRDYE800; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; MALE; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SIGNAL DETECTION; ANIMAL; CELL LINE; CHEMISTRY; DISEASE MODEL; METABOLISM; METHODOLOGY; NUDE MOUSE; OSTEOPOROSIS; WHOLE BODY IMAGING;

ANIMALIA; MUS;

ANIMALS; BIOLOGICAL MARKERS; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CELL LINE; DISEASE MODELS, ANIMAL; FLUORESCEINS; INDOLES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; OSTEOPOROSIS; SPECTROSCOPY, NEAR-INFRARED; TETRACYCLINE; WHOLE BODY IMAGING;

EID: 80155194389     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.05.011     Document Type: Article

References (32)

1. M.J. Allen, Biochemical markers of bone metabolism in animals: uses and limitations, Vet. Clin. Pathol. 32 (2003) 101-113. (Pubitemid 37281086)
2. M. Zaidi, Skeletal remodeling in health and disease, Nat. Med. 13 (2007) 791-801. (Pubitemid 47038187)
3. T.C. Lee, S. Mohsin, D. Taylor, R. Parkesh, T. Gunnlaugsson, F.J. O'Brien, M. Giehl, W. Gowin, Detecting microdamage in bone, J. Anat. 203 (2003) 161-172. (Pubitemid 36974661)
4. B.A. Rahn, Fluorochrome labelling of bone dynamics, Eur. Cells Mater. 5 (2003) 1.
5. M.P. Yavropoulou, J.G. Yovos, Osteoclastogenesis - current knowledge and future perspectives, J. Musculoskelet. Neuronal Interact. 8 (2008) 204-216.
6. A. Zaheer, M. Murshed, A.M. De Grand, T.G. Morgan, G. Karsenty, J.V. Frangioni, Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals, Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1132-1136. (Pubitemid 43732123)
7. J.M. Bernhard, J.K. Blanks, C.J. Hintz, G.T. Chandler, Use of the fluorescent calcite marker calcein to label foraminiferal tests, J. Foraminiferal Res. 34 (2004) 96-101. (Pubitemid 38763765)
8. C. Pautke, S. Vogt, T. Tischer, G. Wexel, H. Deppe, S. Milz, M. Schieker, A. Kolk, Polychrome labeling of bone with seven different fluorochromes: enhancing fluorochrome discrimination by spectral image analysis, Bone 37 (2005) 441-445. (Pubitemid 41317316)
9. H.K. Suzuki, A. Mathews, Two-color fluorescent labeling of mineralizing tissues with tetracycline and 2, 4-bis[N,N′-di-(carbomethyl)aminomethyl] fluorescein, Stain Technol. 41 (1966) 57-60.
10. A. Dhem, N. Piret, D. Fortunati, Tetracyclines, doxycycline, and calcified tissues, Scand. J. Infect. Dis. Suppl. (1976) 42-46.
11. R.A. Milch, D.P. Rall, J.E. Tobie, Fluorescence of tetracycline antibiotics in bone, J. Bone Joint Surg. Am. A 40 (1958) 897-910.
12. B.A. Rahn, S.M. Perren, Alizarin complexone-fluorochrome for bone and dentine labeling, Experientia 28 (1972) 180.
13. B.A. Rahn, S.M. Perren, Xylenol orange, a fluorochrome useful in polychrome sequential labeling of calcifying tissues, Stain Technol. 46 (1971) 125-129.
14. A. Zaheer, R.E. Lenkinski, A. Mahmood, A.G. Jones, L.C. Cantley, J.V. Frangioni, In vivo near-infrared fluorescence imaging of osteoblastic activity, Nat. Biotechnol. 19 (2001) 1148-1154. (Pubitemid 33115701)
15. K.E. Adams, S. Ke, S. Kwon, F. Liang, Z. Fan, Y. Lu, K. Hirschi, M.E. Mawad, M.A. Barry, E.M. Sevick-Muraca, Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer, J. Biomed. Opt. 12 (2007) 024017.
16. J.L. Kovar, M.A. Johnson, W.M. Volcheck, J. Chen, M.A. Simpson, Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model, Am. J. Pathol. 169 (2006) 1415-1426. (Pubitemid 351194374)
17. J.L. Kovar, M.A. Simpson, A. Schutz-Geschwender, D.M. Olive, A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models, Anal. Biochem. 367 (2007) 1-12. (Pubitemid 46938663)
18. T.J. Snoeks, A. Khmelinskii, B.P. Lelieveldt, E.L. Kaijzel, C.W. Lowik, Optical advances in skeletal imaging applied to bone metastases, Bone 48 (2010) 106-114.
19. A. Zaheer, T.E. Wheat, J.V. Frangioni, IRDye78 conjugates for near-infrared fluorescence imaging, Mol. Imaging 1 (2002) 354-364.
20. R.E. Lenkinski, M. Ahmed, A. Zaheer, J.V. Frangioni, S.N. Goldberg, Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer, Acad. Radiol. 10 (2003) 1159-1164. (Pubitemid 37266307)
21. D.D. Thompson, H.A. Simmons, C.M. Pirie, H.Z. Ke, F. DA, FDA guidelines and animal models for osteoporosis, Bone 17 (1995) 125S-133S.
22. D. Wang, K. Christensen, K. Chawla, G. Xiao, P.H. Krebsbach, R.T. Franceschi, Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential, J. Bone Miner. Res. 14 (1999) 893-903. (Pubitemid 29262883)
23. S.A. Marshall, R.N. Jones, A. Wanger, J.A. Washington, G.V. Doern, A.L. Leber, T.H. Haugen, Proposed MIC quality control guidelines for national committee for clinical laboratory standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin Gnovobiocin, pirlimycin, premafloxacin, and spectinomycin, J. Clin. Microbiol. 34 (1996) 2027-2029. (Pubitemid 26239248)
24. Y.H. Wang, Y. Liu, P. Maye, D.W. Rowe, Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes, Biotechnol. Prog. 22 (2006) 1697-1701. (Pubitemid 44912676)
25. C.A. Eddy, Experimental Surgery of the Genital System, Academic Press, Orlando, FL, 1986.
26. A.S. Turner, Animal models of osteoporosis - necessity and limitations, Eur. Cells Mater. 1 (2001) 66-81. (Pubitemid 38956756)
27. S. Khosla, B.L. Riggs, Pathophysiology of age-related bone loss and osteoporosis, Endocrinol. Metab. Clin. N. Am. 34 (2005) 1015-1030. (Pubitemid 41677410)
28. S.K. Lee, Y. Kadono, F. Okada, C. Jacquin, B. Koczon-Jaremko, G. Gronowicz, D.J. Adams, H.L. Aguila, Y. Choi, J.A. Lorenzo, T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy, J. Bone Miner. Res. 21 (2006) 1704-1712. (Pubitemid 46141225)
29. J.M. Cheong, N.S. Gunaratna, G.P. McCabe, G.S. Jackson, A. Kempa-Steczko, C.M. Weaver, Bone-seeking labels as markers for bone turnover: validation of urinary excretion in rats, Osteoporos. Intl. 22 (2011) 153-157.
30. C. Pautke, S. Vogt, K. Kreutzer, C. Haczek, G. Wexel, A. Kolk, A.B. Imhoff, H. Zitzelsberger, S. Milz, T. Tischer, Characterization of eight different tetracyclines: advances in fluorescence bone labeling, J. Anat. 217 (2011) 76-82.
31. D.A. Corral, M. Amling, M. Priemel, E. Loyer, S. Fuchs, P. Ducy, R. Baron, G. Karsenty, Dissociation between bone resorption and bone formation in osteopenic transgenic mice, Proc. Natl. Acad. Sci. USA 95 (1998) 13835-13840. (Pubitemid 28523059)
32. Y. Zhao, J.M. Cheong, W. Lee, M. Wastney, B.R. Martin, C.M. Weaver, Tetracycline and calcium kinetics are comparable for estimating bone resorption in rats, J. Nutr. 140 (2011) 1704-1709.